Home LiteratureArticle Details
PMID: 8842489 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Review

Involvement of heparan sulfate and related molecules in sequestration and growth promoting activity of fibroblast growth factor.

Cancer metastasis reviews ·Vol. 15 ·No. 2 ·1996-06-00 ·Pages 177-86

Vlodavsky I, Miao HQ, Medalion B, Danagher P, Ron D

Abstract

Heparan sulfate proteoglycans (HSPGs) are ubiquitous macromolecules associated with the cell surface and extracellular matrix (ECM) of a wide range of cells of vertebrate and invertebrate tissues [1, 2]. The basic HSPG structure consists of a protein core to which several linear heparan sulfate (HS) chains are covalently attached. The polysaccharide chains are typically composed of repeating hexuronic and D-glucosamine disaccharide units that are substituted to a varying extent with N- and O-linked sulfate moieties and N-linked acetyl groups [1, 2]. Beside serving as a scaffold for the attachment of various ECM components (e.g., collagen, laminin, fibronectin), the binding of HS to certain proteins has been suggested to induce a conformational change which may lead to the exposure of novel reactive determinants or conversely stabilize an inert protein configuration [1-4]. Of particular significance is the interaction of HS with fibroblast growth factors (FGFs), mediating their sequestration, stabilization and high affinity receptor binding and signaling [3-7]. Cellular responses to FGFs may hence be modulated by metabolic inhibitors of HS synthesis and sulfation, HS-degrading enzymes, and synthetic mimetics of heparin/HS. In the present review we focus on the involvement of HS in basic FGF (bFGF) receptor binding and mitogenic activity and its modulation by species of heparin, HS, and synthetic polyanionic 'heparin-mimicking' compounds. The results are discussed in relation to the current thoughts on the dual involvement of low and high affinity receptor sites in the growth promoting and angiogenic activities of bFGF and other heparin-binding growth factors.

MeSH Terms
Animals Cell Division/physiology Extracellular Matrix/physiology Fibroblast Growth Factor 2/physiology Heparin/physiology Heparitin Sulfate/physiology Humans Proteoglycans/physiology
Chemicals
Proteoglycans Fibroblast Growth Factor 2 Heparin Heparitin Sulfate
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Vlodavsky I
Department of Oncology, Hadassah-Hebrew University Hospital, Jerusalem, Israel.
Miao H Q
Medalion B
Danagher P
Ron D
References (56)
56 references, click to expand
  1. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor.
    Cell. 1991 Feb 22;64(4):841-8 PMID: 1847668
  2. Molecular behavior adapts to context: heparanase functions as an extracellular matrix-degrading enzyme or as a T cell adhesion molecule, depending on the local pH.
    J Exp Med. 1995 May 1;181(5):1929-34 PMID: 7722469
  3. Possible regulation of FGF activity by syndecan, an integral membrane heparan sulfate proteoglycan.
    Ann N Y Acad Sci. 1991;638:182-94 PMID: 1785801
  4. Sulfate moieties in the subendothelial extracellular matrix are involved in basic fibroblast growth factor sequestration, dimerization, and stimulation of cell proliferation.
    J Biol Chem. 1996 Mar 1;271(9):4879-86 PMID: 8617759
  5. Control of angiogenesis by heparin and other sulfated polysaccharides.
    Adv Exp Med Biol. 1992;313:355-64 PMID: 1279952
  6. Selective binding of VEGF121 to one of the three vascular endothelial growth factor receptors of vascular endothelial cells.
    J Biol Chem. 1996 Mar 8;271(10):5519-23 PMID: 8621410
  7. Release of cell surface-associated basic fibroblast growth factor by glycosylphosphatidylinositol-specific phospholipase C.
    J Cell Physiol. 1992 Apr;151(1):126-37 PMID: 1313817
  8. Proteoglycans: structures and interactions.
    Annu Rev Biochem. 1991;60:443-75 PMID: 1883201
  9. CXC chemokines connective tissue activating peptide-III and neutrophil activating peptide-2 are heparin/heparan sulfate-degrading enzymes.
    J Biol Chem. 1995 Feb 17;270(7):3268-77 PMID: 7852412
  10. Endothelial cell-derived heparan sulfate binds basic fibroblast growth factor and protects it from proteolytic degradation.
    J Cell Biol. 1988 Aug;107(2):743-51 PMID: 2971068
  11. Control of cell proliferation by heparan sulfate and heparin-binding growth factors.
    Thromb Haemost. 1995 Jul;74(1):534-40 PMID: 8578521
  12. Heparin-mediated release of fibroblast growth factor-like activity into the circulation of rabbits.
    Growth Factors. 1990;3(3):221-9 PMID: 2245043
  13. Human growth hormone and extracellular domain of its receptor: crystal structure of the complex.
    Science. 1992 Jan 17;255(5042):306-12 PMID: 1549776
  14. Biochemical characterization of the molecular interaction between recombinant basic fibroblast growth factor and a recombinant soluble fibroblast growth factor receptor.
    Biochem J. 1993 Sep 15;294 ( Pt 3):639-44 PMID: 8379918
  15. Importance of size and sulfation of heparin in release of basic fibroblast growth factor from the vascular endothelium and extracellular matrix.
    Biochemistry. 1992 Feb 25;31(7):2080-8 PMID: 1536850
  16. Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation.
    Cell. 1994 Dec 16;79(6):1015-24 PMID: 7528103
  17. Reversal of basic fibroblast growth factor-mediated autocrine cell transformation by aromatic anionic compounds.
    Cancer Res. 1992 Oct 15;52(20):5656-62 PMID: 1394189
  18. Chimeric molecules between keratinocyte growth factor and basic fibroblast growth factor define domains that confer receptor binding specificities.
    J Biol Chem. 1995 Dec 15;270(50):29813-8 PMID: 8530375
  19. Heparin protects basic and acidic FGF from inactivation.
    J Cell Physiol. 1986 Sep;128(3):475-84 PMID: 3528177
  20. Proteoglycans on endothelial cells present adhesion-inducing cytokines to leukocytes.
    Immunol Today. 1993 Mar;14(3):111-5 PMID: 8466625
  21. In the clutches of proteoglycans: how does heparan sulfate regulate FGF binding?
    Chem Biol. 1995 Oct;2(10):645-9 PMID: 9383470
  22. Mast cell heparin stimulates migration of capillary endothelial cells in vitro.
    J Exp Med. 1980 Oct 1;152(4):931-44 PMID: 7420025
  23. A unique heparan sulfate in the nuclei of hepatocytes: structural changes with the growth state of the cells.
    J Cell Biol. 1986 Feb;102(2):587-99 PMID: 2935544
  24. Heparan sulfate primed on beta-D-xylosides restores binding of basic fibroblast growth factor.
    J Cell Biochem. 1995 Feb;57(2):173-84 PMID: 7759555
  25. Heparin increases the affinity of basic fibroblast growth factor for its receptor but is not required for binding.
    J Biol Chem. 1994 Feb 11;269(6):3976-84 PMID: 8307953
  26. Heparan sulphate bound growth factors: a mechanism for stromal cell mediated haemopoiesis.
    Nature. 1988 Mar 24;332(6162):376-8 PMID: 2965305
  27. An essential heparin-binding domain in the fibroblast growth factor receptor kinase.
    Science. 1993 Mar 26;259(5103):1918-21 PMID: 8456318
  28. Basic fibroblast growth factor (bFGF) dissociates rapidly from heparan sulfates but slowly from receptors. Implications for mechanisms of bFGF release from pericellular matrix.
    J Biol Chem. 1992 Dec 25;267(36):25803-9 PMID: 1464594
  29. A new class of steroids inhibits angiogenesis in the presence of heparin or a heparin fragment.
    Science. 1985 Dec 20;230(4732):1375-8 PMID: 2416056
  30. Regulation of growth factor activation by proteoglycans: what is the role of the low affinity receptors?
    Cell. 1995 Nov 3;83(3):357-60 PMID: 8521464
  31. Proteoglycans as modulators of growth factor activities.
    Cell. 1991 Mar 8;64(5):867-9 PMID: 2001586
  32. Activating and inhibitory heparin sequences for FGF-2 (basic FGF). Distinct requirements for FGF-1, FGF-2, and FGF-4.
    J Biol Chem. 1993 Nov 15;268(32):23906-14 PMID: 7693696
  33. Basic fibroblast growth factor is internalized through both receptor-mediated and heparan sulfate-mediated mechanisms.
    J Biol Chem. 1992 Nov 5;267(31):22156-62 PMID: 1429568
  34. Thrombin-induced release of active basic fibroblast growth factor-heparan sulfate complexes from subendothelial extracellular matrix.
    Blood. 1993 Jun 15;81(12):3324-31 PMID: 8507869
  35. Angiogenesis.
    J Biol Chem. 1992 Jun 5;267(16):10931-4 PMID: 1375931
  36. Distribution of basic fibroblast growth factor in the 18-day rat fetus: localization in the basement membranes of diverse tissues.
    J Cell Biol. 1990 Mar;110(3):753-65 PMID: 1689733
  37. High affinity immunoreactive FGF receptors in the extracellular matrix of vascular endothelial cells--implications for the modulation of FGF-2.
    J Cell Biol. 1995 Mar;128(6):1221-8 PMID: 7896883
  38. Phospholipase C release of basic fibroblast growth factor from human bone marrow cultures as a biologically active complex with a phosphatidylinositol-anchored heparan sulfate proteoglycan.
    J Cell Biol. 1991 Sep;114(6):1275-83 PMID: 1654337
  39. Expression of basic fibroblast growth factor in normal human tissues.
    Lab Invest. 1990 Dec;63(6):832-40 PMID: 2255190
  40. Heparinase inhibits neovascularization.
    Proc Natl Acad Sci U S A. 1994 Feb 15;91(4):1524-8 PMID: 7509076
  41. Differential effect of cell-associated heparan sulfates on the binding of keratinocyte growth factor (KGF) and acidic fibroblast growth factor to the KGF receptor.
    J Biol Chem. 1994 Dec 23;269(51):32279-85 PMID: 7528211
  42. Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis.
    Cell. 1994 Dec 16;79(6):1005-13 PMID: 7528102
  43. Extracellular sequestration and release of fibroblast growth factor: a regulatory mechanism?
    Trends Biochem Sci. 1991 Jul;16(7):268-71 PMID: 1926336
  44. Heparin affinity: purification of a tumor-derived capillary endothelial cell growth factor.
    Science. 1984 Mar 23;223(4642):1296-9 PMID: 6199844
  45. Differential structural requirements of heparin and heparan sulfate proteoglycans that promote binding of basic fibroblast growth factor to its receptor.
    J Biol Chem. 1994 Jan 7;269(1):114-21 PMID: 8276782
  46. Antiproliferative activity to vascular smooth muscle cells and receptor binding of heparin-mimicking polyaromatic anionic compounds.
    Arterioscler Thromb. 1994 Dec;14(12):1992-9 PMID: 7981190
  47. Heparanase activity expressed by platelets, neutrophils, and lymphoma cells releases active fibroblast growth factor from extracellular matrix.
    Cell Regul. 1990 Oct;1(11):833-42 PMID: 2088528
  48. Multivalent ligand-receptor binding interactions in the fibroblast growth factor system produce a cooperative growth factor and heparin mechanism for receptor dimerization.
    Biochemistry. 1994 Aug 30;33(34):10229-48 PMID: 7520751
  49. Glycosaminoglycans: molecular properties, protein interactions, and role in physiological processes.
    Physiol Rev. 1991 Apr;71(2):481-539 PMID: 2006221
  50. Angiogenic factors.
    Science. 1987 Jan 23;235(4787):442-7 PMID: 2432664
  51. Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells.
    Mol Cell Biol. 1992 Jan;12(1):240-7 PMID: 1309590
  52. Human endothelial cells: use of heparin in cloning and long-term serial cultivation.
    Science. 1983 Nov 11;222(4624):623-5 PMID: 6635659
  53. A heparin-binding angiogenic protein--basic fibroblast growth factor--is stored within basement membrane.
    Am J Pathol. 1988 Feb;130(2):393-400 PMID: 3277442
  54. Endothelial cell-derived basic fibroblast growth factor: synthesis and deposition into subendothelial extracellular matrix.
    Proc Natl Acad Sci U S A. 1987 Apr;84(8):2292-6 PMID: 3470794
  55. Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like molecules.
    Biochemistry. 1989 Feb 21;28(4):1737-43 PMID: 2541764
  56. Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity.
    J Cell Biol. 1990 Mar;110(3):767-75 PMID: 2137829
Article Info
Journal
Cancer metastasis reviews
Abbr.
Cancer Metastasis Rev
ISSN
0167-7659
Published
1996-06-00
Pages
177-86
Language
English
Region
Netherlands
NLM ID
8605731
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]